提醒

CSL Limited (CSLLY)

OTC Markets OTCQX: CSLLY · 实时价格 · USD

31.00

-0.36 (-1.15%)

收盘价： Aug 26, 2026, 3:59 PM

股价、关键数字和最新消息，都在这一页。

-1.15% (1D)

买价	30.93
市值	59.39B
营收（TTM）	15.8B
净利润（TTM）	-2.58B
	0.09
	-1.32
	n/a
	18.66
市净率（TTM）	4.01
市销率（TTM）	3.76
财报日期	Feb 9, 2027

卖价	30.98
成交量	14,496
20日均量	374,128
开盘价	29.75
前收盘价	31.36
日内区间	29.75 - 31.00
52周区间	16.01 - 36.28
分析师	Hold
目标价	28.4 (-8.39%)
分红	$0.72 (2.34%)
除息日	2026年9月10日

关于 CSLLY

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. The CSL Seqi...

[阅读更多]

行业 Biotechnology

板块 Healthcare

上市日期 Dec 29, 2009

员工人数 29,000

交易所 OTC Markets OTCQX

股票代码 CSLLY

官网 https://www.csl.com

公司完整简介

财务表现

2026年，CSL的营收为15.7B，较上一年的15.43B增长1.74%。净利润为-2.58B，下降-185.91%。

财务报表

分析师预测

根据1位分析师的评级，CSLLY的平均评级为“Hold”。12个月目标价为28.4，较最新价格下跌空间8.39%。

股票预测

下次财报发布时间

CSL Limited 的下次财报预计于 Feb 9, 2027, 盘中。
分析师预计营收为 ... 升级

新闻

1月前 · Investing.com

Australia to challenge Trump’s new 12.5% tariff, says PM Albanese

Investing.com -- Australian Prime Minister Anthony Albanese said he would raise Washington’s new 12.5% tariff on Australian goods directly with U.S. President Donald Trump, Reuters reported.

2月前 · The Wall Street Journal

European Regulator Calls for Amgen’s Tavneos to Have Authorization Revoked

The committee is recommending that no new patients start treatment with Tavneos and that existing patients be switched to suitable alternatives.

3月前 · Proactive

Imugene strengthens board with biotech and pharma appointments

Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has appointed Dr Charmaine Gittleson and Michael Kotsanis as non-executive directors as part of a board enhancement process aimed at supporting the company’s ...

3月前 · Simply Wall St.

3 ASX Dividend Stocks Yielding Up To 4.2%

As the Australian market grapples with global uncertainties and fluctuating commodity prices, investors are increasingly seeking stability amidst the volatility. In such an environment, dividend stock...

3月前 · GuruFocus.com

CSL Plunges 22% After Cutting Outlook And Flagging $5 Billion Impairments

CSL now expects weaker full-year revenue and profit as plasma, China pricing, and Vifor pressures weigh on performance.

第 1 页，共 2 页

CSL Limited (CSLLY)

关于 CSLLY

财务表现

分析师预测